- WORLD EDITIONAustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Pharmaceutical Sales Anticipated to Reach $1.3 Trillion in 2018
A new report anticipates that global pharmaceutical sales will reach $1.3 trillion by 2018.
A new report anticipates that global pharmaceutical sales will reach $1.3 trillion by 2018.
According to an article on PharmaTimes:
Worldwide sales passed the $1 trillion mark for the first time in 2014, and the 2015 CMR Pharmaceutical R&D Factbook from Thomson Reuters predicts that this increase will continue coupled with a rise in R&D productivity.
The authors note that 2014 saw the highest number of first-world new molecular entity (NME) launches in over a decade, with 46 such drugs entering the market. They say that this goes against perceptions that the industry is in a “era of scarcity”.
One third of these drugs were for rare indications, and more than 65% were speciality drugs for the treatment of cancer, hepatitis C and HIV.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.